The prognostic and predictive impact of genomic grade index (GGI) versus central grade or molecular class in intermediate-risk breast cancer (BC): Results from the EC-Doc trial.
Oleg Gluz
No relevant relationships to disclose
Cornelia Liedtke
No relevant relationships to disclose
Helene P. Peyro Saint Paul
No relevant relationships to disclose
Ulrike Nitz
No relevant relationships to disclose
Ronald E. Kates
No relevant relationships to disclose
Jens Bodo Huober
No relevant relationships to disclose
Arndt Hartmann
No relevant relationships to disclose
Hans Heinrich Kreipe
No relevant relationships to disclose
Enrico Pelz
No relevant relationships to disclose
Ramona Erber
No relevant relationships to disclose
Walther Kuhn
No relevant relationships to disclose
Nadia Harbeck
No relevant relationships to disclose